Drugs / C-Tb
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01242475 | Apr → Nov 2011 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-Tb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01242475 ↗ |
| Modality | Diagnostic / imaging agent | “A Phase IIa Specificity Trial of the Diagnostic Agent C-Tb, When Given Intradermally by the Mantoux Technique” NCT01242475 ↗ |
| Route | Other | “given intradermally by the Mantoux technique” NCT01242475 ↗ |